Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Antonelli

Showing results (471-480 of 858) with videos related to

Pageof 86
Sort By:
BJU International|April 16, 2024
Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: a systematic review and meta-analysis of comparative studiesFrancesco Ditonno, Alessandro Veccia, Francesca Montanaro, et al.
Virchows Archiv : an International Journal of Pathology|May 11, 2026
The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolutionEnrico Munari, Pietro Antonini, Luca Cima, et al.
Cancers|January 11, 2025
Robot-Assisted PSMA-Radioguided Salvage Surgery for Oligorecurrent Prostate Cancer Using the Novel SENSEI<sup>®</sup> Drop-in Gamma Probe: Correlation of Intraoperative Measurements to Preoperative Imaging and Final HistologyGiovanni Mazzucato, Fabian Falkenbach, Marie-Lena Schmalhofer, et al.
Clinical Genitourinary Cancer|June 3, 2020
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific MortalityCarlotta Palumbo, Elio Mazzone, Francesco A Mistretta, et al.
European Urology Focus|May 28, 2020
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and HistologyCarlotta Palumbo, Angela Pecoraro, Sophie Knipper, et al.
International Journal of Molecular Sciences|May 28, 2022
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid CancerFrancesca Ragusa, Silvia Martina Ferrari, Giusy Elia, et al.
World Journal of Urology|June 28, 2020
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary groupLilia Bardoscia, Luca Triggiani, Marco Sandri, et al.
Medicina (Kaunas, Lithuania)|October 29, 2025
The Role of Near-Infrared Fluorescence with Indocyanine Green in Robot-Assisted Partial Nephrectomy: Results from an Updated Systematic Review and Meta-Analyses of Controlled StudiesAndrea Panunzio, Rossella Orlando, Federico Greco, et al.
European Urology Open Science|April 9, 2024
Intraoperative Performance of DaVinci Versus Hugo RAS During Radical Prostatectomy: Focus on Timing, Malfunctioning, Complications, and User Satisfaction in 100 Consecutive Cases (the COMPAR-P Trial)Alessandro Antonelli, Alessandro Veccia, Sarah Malandra, et al.
International Journal of Molecular Sciences|June 27, 2024
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In VitroSilvia Martina Ferrari, Francesca Ragusa, Giusy Elia, et al.
Pageof 86

Showing results (471-480 of 858) with videos related to

Sort By:
Pageof 86
BJU International|April 16, 2024
Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: a systematic review and meta-analysis of comparative studiesFrancesco Ditonno, Alessandro Veccia, Francesca Montanaro, et al.
Virchows Archiv : an International Journal of Pathology|May 11, 2026
The evolution of prostate cancer grading: from Gleason score to risk taxonomy and the artificial intelligence revolutionEnrico Munari, Pietro Antonini, Luca Cima, et al.
Cancers|January 11, 2025
Robot-Assisted PSMA-Radioguided Salvage Surgery for Oligorecurrent Prostate Cancer Using the Novel SENSEI<sup>®</sup> Drop-in Gamma Probe: Correlation of Intraoperative Measurements to Preoperative Imaging and Final HistologyGiovanni Mazzucato, Fabian Falkenbach, Marie-Lena Schmalhofer, et al.
Clinical Genitourinary Cancer|June 3, 2020
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific MortalityCarlotta Palumbo, Elio Mazzone, Francesco A Mistretta, et al.
European Urology Focus|May 28, 2020
Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and HistologyCarlotta Palumbo, Angela Pecoraro, Sophie Knipper, et al.
International Journal of Molecular Sciences|May 28, 2022
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid CancerFrancesca Ragusa, Silvia Martina Ferrari, Giusy Elia, et al.
World Journal of Urology|June 28, 2020
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary groupLilia Bardoscia, Luca Triggiani, Marco Sandri, et al.
Medicina (Kaunas, Lithuania)|October 29, 2025
The Role of Near-Infrared Fluorescence with Indocyanine Green in Robot-Assisted Partial Nephrectomy: Results from an Updated Systematic Review and Meta-Analyses of Controlled StudiesAndrea Panunzio, Rossella Orlando, Federico Greco, et al.
European Urology Open Science|April 9, 2024
Intraoperative Performance of DaVinci Versus Hugo RAS During Radical Prostatectomy: Focus on Timing, Malfunctioning, Complications, and User Satisfaction in 100 Consecutive Cases (the COMPAR-P Trial)Alessandro Antonelli, Alessandro Veccia, Sarah Malandra, et al.
International Journal of Molecular Sciences|June 27, 2024
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In VitroSilvia Martina Ferrari, Francesca Ragusa, Giusy Elia, et al.
Pageof 86